(65 days)
Not Found
No
The summary describes a passive surgical mesh made of polypropylene, with no mention of software, data processing, or AI/ML terms. The predicate devices are also traditional surgical meshes.
No.
The device description indicates it is an implantable sheet for reinforcement, which is not typically classified as a therapeutic device in the sense of delivering active treatment or therapy. It serves a structural support function.
No
Explanation: The device is described as a synthetic implantable sheet for reinforcing connective tissue, indicated for hernioplasty and repair of fascial defects. Its function is to provide structural support, not to diagnose a medical condition.
No
The device description clearly states it is a synthetic implantable sheet made of monofilament polypropylene, which is a physical material, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "hernioplasty and repair of other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result." This describes a surgical implant used in vivo (within the body) to repair tissue.
- Device Description: The device is described as a "synthetic implantable sheet for the reinforcement of connective tissue structures." This further confirms its use as an implantable medical device.
- Lack of IVD Characteristics: IVD devices are used in vitro (outside the body) to examine specimens (like blood, urine, or tissue) to provide information about a person's health. The provided description does not mention any such use or interaction with biological specimens for diagnostic purposes.
Therefore, Optilene Mesh LP is a surgical implant, not an IVD.
N/A
Intended Use / Indications for Use
Optilene Mesh LP is indicated for hernioplasty and repair of other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Product codes
FTL
Device Description
Optilene Mesh LP is a synthetic implantable sheet for the reinforcement of connective tissue structures. It consists of monofilament polypropylene, which is knitted into a dimensionally stable, thin, and flexible net that is cut into various sizes and shapes.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Ethicon Prolene Polypropylene Mesh (K962530), Ethicon Prolene Soft Polypropylene Mesh (K001122)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
JAN ] 8 2006
510(k) SUMMARY (as required by 21 CFR 807.92) B.
Optilene® Mesh LP 17 November 2005
| COMPANY: | Aesculap®, Inc.
3773 Corporate Parkway
Center Valley, PA 18034
Establishment Registration Number: 2916714 |
|----------------------|--------------------------------------------------------------------------------------------------------------------|
| CONTACT: | Matthew M. Hull
610-984-9072 (phone)
610-791-6882 (fax) |
| TRADE NAME: | Optilene® Mesh LP |
| COMMON NAME: | Surgical Mesh |
| CLASSIFICATION NAME: | Mesh, Surgical, Polymeric |
| REGULATION NUMBER: | 878.3300 |
| PRODUCT CODE: | FTL |
SUBSTANTIAL EQUIVALENCE
Aesculap®, Inc. believes that the device name is substantially equivalent to:
Ethicon Prolene Polypropylene Mesh (K962530)
Ethicon Prolene Soft Polypropylene Mesh (K001122)
DEVICE DESCRIPTION
Optilene Mesh LP is a synthetic implantable sheet for the reinforcement of connective tissue structures. It consists of monofilament polypropylene, which is knitted into a dimensionally stable, thin, and flexible net that is cut into various sizes and shapes.
INDICATIONS FOR USE
Optilene Mesh LP is indicated for hernioplasty and repair of other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
TECHNOLIGICAL CHARACTERISTICS(compared to Predicate(s))
Both of these meshes are woven from monofilament polypropylene nonabsorbable suture material. Optilene Mesh LP and Prolene Mesh are also marketed in similar shapes and sizes that are packaged as sterile single use devices.
1
Image /page/1/Picture/1 description: The image shows the logo for the Department of Health and Human Services, USA. The logo features a stylized eagle with three lines forming its body and head, enclosed within a circular border. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" is arranged around the circumference of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JAN 1 8 2006
Mr. Matthew M. Hull, RAC Manager, Regulatory Affairs Aesculap, Inc. 3773 Corporate Parkway Center Valley, Pennsylvania 18034
Re: K053158
Trade/Device Name: Optilene Mesh LP Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical Mesh Regulatory Class: II Product Code: FTL Dated: January 4, 2006 Received: January 5, 2006
Dear Mr. Hull:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Mr. Hull
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Madel N. Millare
Mark N. Melkerson Acting Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
Page 1 of 1
A. INDICATIONS FOR USE STATEMENT
510(k) Number: K053158
Device Name: Optilene Mesh LP
Indications for Use:
Optilene Mesh LP is indicated for hernioplasty and repair of other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Prescription Use _ _ _ X _ _ _ and/or _ Over-the-Counter Use _
(per 21 CFR 801 Subpart D)
(per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of General, Pestorative, and Neurological Devices
510(k) Number |( o ≤ 3 ) 58